12 September 2024 @ 15:27
Case: Characterizing a Cancer Immunotherapy Target with Genomic Data
Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service
12 September 2024 @ 15:27
Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service
15 August 2024 @ 10:24
Dr. Vibhu Sahni shares his experiences with our Virtual Bioinformatics Core service
29 April 2024 @ 15:24
Dr. Henri Huttunen from Herantis Pharma shares his experiences with our Virtual Bioinformatics Core service
13 December 2023 @ 15:00
Dr. Eric Feraille shares his experiences of our service
1 December 2023 @ 17:00
Dr. Rhoel Dinglasan shares his experiences of our Virtual Bioinformatics Core service
17 September 2023 @ 14:20
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
29 May 2023 @ 12:12
Learn how Professor Filgueira benefited from our transcriptomic data analysis service
13 March 2023 @ 09:54
We helped a researcher explore public data to study the biomarker and drug-targed potential of glypicans
6 March 2023 @ 13:18
Learn how a research group used our expertise to study the effects of cancer-predisposing variants
3 March 2023 @ 12:50
Learn how Amazentis leveraged omics analyses in a clinical trial for a postbiotic
4 November 2022 @ 14:49
Learn how RNA-seq and epigenomic data come together to reveal gene-regulatory programs
30 September 2022 @ 14:35
Presenting Dr. Flint, the winner of Genevia RNA-Seq Bioinformatics Grant 2022
8 February 2022 @ 13:54
Learn how Genevia Technologies helped Alimetrics uncover gene expression differences in an animal feed additive study.
9 June 2021 @ 14:28
Key points to keep in mind when interpreting results from an expression analysis
7 June 2021 @ 14:46
Learn how Genevia Technologies helped Barron Biomedical to identify a target for cancer therapy.
27 May 2021 @ 16:18
Learn how machine learning enables risk stratification using high-throughput data
17 March 2021 @ 16:26
Learn how Genevia Technologies helped with FastEV's commercialization.
2 March 2021 @ 19:50
Learn how Genevia Technologies helped MiNa TX with mechanism of action analysis.
25 August 2020 @ 15:36
Learn about how KCT identified new biomarkers for a macrophage subtype of their interest.
11 June 2020 @ 14:02
Learn about how Epitherapeutics used NGS to elucidate the mechanism of action of their drug
14 May 2020 @ 08:22
Learn about how Ark Therapeutics ensured their lead molecule had no significant genomic off-targets
3 March 2020 @ 08:50
Learn about how Roal got multiple new product candidates using NGS
15 January 2020 @ 10:34
Learn how a research group uncovered time-wise gene expression patterns
17 December 2019 @ 10:38
Learn about how a biologist learned to analyze her RNA-seq data
12 September 2019 @ 10:51
Learn about how a research group in Lund University got a state-of-the-art predictive model utilizing gene expression and clinical data from over 4000 patient samples
15 May 2019 @ 11:13
Learn about how Roal Oy entered the world of high-throughput genomics
15 April 2019 @ 11:25
Learn about how a research group with limited bioinformatics resources got flexible expert support for their analysis
12 March 2019 @ 11:29
Learn about how Pharmatest ensured that their cell lines are exactly what they are supposed to be
26 February 2019 @ 11:37
Learn about how TATAA Biocenter could provide fast, yet customized bioinformatics support for their client
18 February 2019 @ 11:41
Learn about how a plant biology group solved their data analysis bottleneck
17 January 2019 @ 11:45
Learn about how the genetic modification of a disease model was validated
25 April 2018 @ 13:47
When, if ever, is using microarrays better than RNA-seq?